Alkermes plc. Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Alkermes plc. (ALKS) had Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $1.76 million as of 2020-06-30, per its 10-Q filed 2020-07-29.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Held-to-Maturity, Maturity › Debt Securities, Held-to-Maturity, Fair Value, Maturity
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2020-07-29
- 2020-06-30: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.76M.
- 2019-12-31: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.77M.
- 2019-09-30: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.72M.
- 2019-06-30: Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $1.79M.
| Period end | Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2020-06-30 | $1.76M 10-Q · filed 2020-07-29 |
| 2019-12-31 | $1.77M 10-K · filed 2020-02-13 |
| 2019-09-30 | $1.72M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $1.79M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $1.77M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $1.80M 10-K · filed 2019-02-15 |
| 2018-09-30 | $1.82M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $1.84M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $1.94M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $1.89M 10-K · filed 2018-02-16 |
| 2017-09-30 | $1.86M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $1.80M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $1.68M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $1.66M 10-K · filed 2017-02-17 |
| 2016-09-30 | $1.67M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $1.67M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $1.67M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $1.67M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |